Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04622319
Brief Title: A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)

First Submitted : November 2, 2020
First Submitted that Met QC Criteria : November 6, 2020
First Posted : November 9, 2020

Last Update Submitted that Met QC Criteria : April 8, 2021
Last Update Posted : April 9, 2021